Balance Sheet Insights: Asensus Surgical Inc (ASXC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Asensus Surgical Inc (AMEX: ASXC) closed at $0.33 down -0.24% from its previous closing price of $0.34. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 3.08 million shares were traded. ASXC stock price reached its highest trading level at $0.338 during the session, while it also had its lowest trading level at $0.3278.

Ratios:

For a deeper understanding of Asensus Surgical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.69 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.34.

On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.

On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 14 ’23 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.

Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14 ’23. The Director now owns 0 shares after completing the transaction at $0.28 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 91490128 and an Enterprise Value of 88643648. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.47 while its Price-to-Book (P/B) ratio in mrq is 6.99. Its current Enterprise Value per Revenue stands at 10.161 whereas that against EBITDA is -1.261.

Stock Price History:

The Beta on a monthly basis for ASXC is 1.38, which has changed by -0.36538464 over the last 52 weeks, in comparison to a change of 0.24919295 over the same period for the S&P500. Over the past 52 weeks, ASXC has reached a high of $0.65, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 18.68%, while the 200-Day Moving Average is calculated to be 22.05%.

Shares Statistics:

For the past three months, ASXC has traded an average of 2.27M shares per day and 2030780 over the past ten days. A total of 272.62M shares are outstanding, with a floating share count of 267.02M. Insiders hold about 2.05% of the company’s shares, while institutions hold 9.11% stake in the company. Shares short for ASXC as of 1718323200 were 11473282 with a Short Ratio of 5.04, compared to 1715731200 on 14397300. Therefore, it implies a Short% of Shares Outstanding of 11473282 and a Short% of Float of 4.3.

Most Popular